The relative importance of cysteine peptidases in osteoarthritis

Journal of Rheumatology

Volumn 27, Issue 8, 2000, Pages 1970-1979

  Lang, A ^a   Horler, D ^a   Baici, A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cartilage; Cathepsins; Histochemistry; Immunocytochemist ry; Osteoarthritis; Osteophytes

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CYSTEINE PROTEINASE; PEPTIDASE;

ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; BONE REMODELING; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; OSTEOARTHRITIS; OSTEOCLAST; OSTEOPHYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; CARTILAGE, ARTICULAR; CATHEPSIN B; CATHEPSINS; CELLS, CULTURED; CHONDROCYTES; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; FEMALE; FEMUR HEAD; HUMANS; IMMUNOENZYME TECHNIQUES; LYSOSOMES; MALE; OSTEOARTHRITIS, HIP;

EID: 0033848451     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Cysteine proteinases and metastasis
2. Multiple enzyme forms from a single gene and their relation to cancer
3. Cathepsin B and human tumor progression
4. The major excreted protein of transformed fibroblasts is an activatable acid-protease
5. The identification of the major excreted protein from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L
6. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour- cell lines
7. Membrane-associated cathepsin L: A role in metastasis of melanomas
8. Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH
9. Biochemical and immunological studies of lysosomal and related proteinases in health and disease
10. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis
11. Cathepsin B in osteoarthritis: Zonal variation of enzyme activity in human femoral head cartilage
12. Cathepsin B in osteoarthritis: Cytochemical and histochemical analysis of human femoral head cartilage
13. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis - A parallel investigation by semiquantitative reverse transcriptasepolymerase chain reaction and immunohistochemistry
14. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization
15. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis
16. Characterisation of fibroblast like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes
17. Mode of activation of the precursor to cathepsin L: Implication for matrix degradation in arthritis
18. Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis
19. Human cathepsin 02, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution
20. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification
21. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues
22. Cathepsin expression during skeletal development
23. Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B
24. Cathepsin B as a marker of the dedifferentiated chondrocyte phenotype
25. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases
26. Differential expression of mRNAs for endopeptidases in phenotypically modulated ('dedifferentiated') human articular chondrocytes
27. Enzymes involved in degradation of cartilage in osteoarthrosis
28. Purification of cathepsin B by a new form of affinity chromatography
29. Simultaneous isolation of human kidney cathepsins B, H, L and C and their characterisation
30. Nomenclature and symbolism for amino acids and peptides. Recommendations 1983
31. Cathepsin B secretion by rabbit articular chondrocytes: Modulation by cycloheximide and glycosaminoglycans
32. Use of the avidin-biotin-peroxidase complex method for the localization of rabbit cathepsin B in cells and tissues
33. Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-Phe-AlaCH2F
34. Use of new synthetic substrates for assays of cathepsin L and cathepsin B
35. Cathepsin B, cathepsin H, and cathepsin L
36. Human cathepsin 02, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin 02 in Spodoptera frugiperda and characterization of the enzyme
37. Molecular design of potent inhibitor specific for cathepsin B based on the tertiary structure prediction
38. Specific assay method for the activities of cathepsin L-type cysteine proteinases
39. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L
40. Localization and cytophotometric analysis of cathepsin B activity in unfixed and undecalcified cryostat sections of whole rat knee joints
41. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts
42. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts
43. Cathepsin K, but not cathepsin B, L, or S, is abundantly expressed in human osteoclasts
44. Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone
45. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
46. Expression of cathepsin K in the human embryo and fetus
47. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteinases
48. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L
49. High-affinity binding of two molecules of cysteine proteinases to low-molecular-weight kininogen
50. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue
51. Sequence analysis and distribution of two new human cathepsin L splice variants
52. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: Possible role of the mannose 6-phosphate/IGF-II receptor